Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway

References

• Alkhalidy H, Moore W, Wang Y, Luo J, McMillan RP, Zhen W, Zhou K, Liu D. 2018. The flavonoid kaempferol ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production. Molecules. 23:2338.
   PubMed Web of Science ®Google Scholar
• Aryan L, Younessi D, Zargari M, Banerjee S, Agopian J, Rahman S, Borna R, Ruffenach G, Umar S, Eghbali M. 2020. The role of estrogen receptors in cardiovascular disease. Int J Mol Sci. 21:4314.
   PubMed Web of Science ®Google Scholar
• Barton M, Prossnitz ER. 2015. Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol Metab. 26(4):185–192.
   PubMed Web of Science ®Google Scholar
• Chang W, Zhu F, Zheng H, Zhou Z, Miao P, Zhao L, Mao Z. 2019. Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: an implication in the treatment of atherosclerosis. Mol Immunol. 116:73–79.
   PubMed Web of Science ®Google Scholar
• Che J, Liang B, Zhang Y, Wang Y, Tang J, Shi G. 2017. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of autophagy via inhibiting PI3K/Akt/mTOR pathway in human endothelial cells. Cardiovasc Pathol. 31:57–62.
   PubMed Web of Science ®Google Scholar
• Chen S, Li X, Wang Y, Mu P, Chen C, Huang P, Liu D. 2019. Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion-induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Mol Med Rep. 19:3633–3641.
   PubMed Web of Science ®Google Scholar
• Cho SH, Jeong MH, Sim DS, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. 2011. Diagnostic value of nitroglycerin-induced headache as a negative predictor of coronary atherosclerosis. Chonnam Med J. 47(1):14–19.
   PubMedGoogle Scholar
• Dworatzek E, Mahmoodzadeh S. 2017. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system. Pharmacol Res. 119:27–35.
   PubMed Web of Science ®Google Scholar
• Fan DX, Yang XH, Li YN, Guo L. 2018. 17β-Estradiol on the expression of G-protein coupled estrogen receptor (GPER/GPR30) mitophagy, and the PI3K/Akt signaling pathway in ATDC5 chondrocytes in vitro. Med Sci Monit. 24:1936–1947.
   PubMed Web of Science ®Google Scholar
• Filardo EJ. 2018. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: dysregulated glandular homeostasis, survival and metastasis. J Steroid Biochem Mol Biol. 176:38–48.
   PubMed Web of Science ®Google Scholar
• Fredman G, Tabas I. 2017. Boosting inflammation resolution in atherosclerosis: the next frontier for therapy. Am J Pathol. 187(6):1211–1221.
   PubMed Web of Science ®Google Scholar
• Gencel VB, Benjamin MM, Bahou SN, Khalil RA. 2012. Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini Rev Med Chem. 12(2):149–174.
   PubMed Web of Science ®Google Scholar
• Grande F, Occhiuzzi MA, Lappano R, Cirillo F, Guzzi R, Garofalo A, Jacquot Y, Maggiolini M, Rizzuti B. 2020. Computational approaches for the discovery of GPER targeting compounds. Front Endocrinol. 11:517.
   PubMed Web of Science ®Google Scholar
• Gu L, Ye P, Li H, Wang Y, Xu Y, Tian Q, Lei G, Zhao C, Gao Z, Zhao W, et al. 2019. Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE–/– mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway. FASEB J. 33(4):4836–4850.
   PubMed Web of Science ®Google Scholar
• Han G, Li F, Yu X, White RE. 2013. GPER: a novel target for non-genomic estrogen action in the cardiovascular system. Pharmacol Res. 71:53–60.
   PubMed Web of Science ®Google Scholar
• Hu H, Wang C, Jin Y, Meng Q, Liu Q, Liu Z, Liu K, Liu X, Sun H. 2019. Catalpol inhibits homocysteine-induced oxidation and inflammation via inhibiting Nox4/NF-κB and GRP78/PERK pathways in human aorta endothelial cells. Inflammation. 42(1):64–80.
   PubMed Web of Science ®Google Scholar
• Huang D, Jia Z, Chang L, Zhou H, Wu X, Wei C. 2020. The role of collateral disease theory in the prevention and treatment of atherosclerosis in post-menopausal women: a narrative review. Ann Palliat Med. 9(4):2314–2322.
   PubMed Web of Science ®Google Scholar
• Hwang YP, Jeong HG. 2010. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol. 242(1):18–28.
   PubMed Web of Science ®Google Scholar
• Jian X, Liu Y, Zhao Z, Zhao L, Wang D, Liu Q. 2019. The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity. Biomed Pharmacother. 118:109375.
   PubMed Web of Science ®Google Scholar
• Jing Y, Cai D, Chen Q, Xiong Q, Hu T, Yao Y, Lin C, Sun X, Lu Y, Kong X, et al. 2017. Liuwei Dihuang soft capsules attenuates endothelial cell apoptosis to prevent atherosclerosis through GPR30-mediated regulation in ovariectomized ApoE-deficient mice. J Ethnopharmacol. 208:185–198.
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Kanuri SH, Mehta JL. 2019. Role of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem. 26(9):1693–1700.
   PubMed Web of Science ®Google Scholar
• Kim TW, Lee SY, Kim M, Cheon C, Ko SG. 2018. Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells. Cell Death Dis. 9(9):875.
   PubMedGoogle Scholar
• Kirichenko TV, Myasoedova VA, Orekhova VA, Ravani AL, Nikitina NA, Grechko AV, Sobenin IA, Orekhov AN. 2017. Phytoestrogen-rich natural preparation for treatment of climacteric syndrome and atherosclerosis prevention in perimenopausal women. Phytother Res. 31(8):1209–1214.
   PubMed Web of Science ®Google Scholar
• Kiyama R. 2017. Estrogenic potentials of traditional Chinese medicine. Am J Chin Med. 45(7):1365–1399.
   PubMed Web of Science ®Google Scholar
• Lagari VS, Levis S. 2013. Phytoestrogens in the prevention of postmenopausal bone loss. J Clin Densitom. 16(4):445–449.
   PubMed Web of Science ®Google Scholar
• Langasco R, Fancello S, Rassu G, Cossu M, Cavalli R, Galleri G, Giunchedi P, Migheli R, Gavini E. 2019. Increasing protective activity of genistein by loading into transfersomes: a new potential adjuvant in the oxidative stress-related neurodegenerative diseases? Phytomedicine. 52:23–31.
   PubMed Web of Science ®Google Scholar
• Lee YT, Lin HY, Chan YW, Li KH, To OT, Yan BP, Liu T, Li G, Wong WT, Keung W, et al. 2017. Mouse models of atherosclerosis: a historical perspective and recent advances. Lipids Health Dis. 16(1):12.
   PubMedGoogle Scholar
• Li TT, Wang ZB, Li Y, Cao F, Yang BY, Kuang HX. 2019. The mechanisms of traditional Chinese medicine underlying the prevention and treatment of atherosclerosis. Chin J Nat Med. 17(6):401–412.
   PubMed Web of Science ®Google Scholar
• Malekmohammad K, Sewell RDE, Rafieian-Kopaei M. 2019. Antioxidants and atherosclerosis: mechanistic aspects. Biomolecules. 9:301.
   PubMed Web of Science ®Google Scholar
• McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, Bild DE, Shea S, Liu K, Watson KE, et al. 2015. 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (multi-ethnic study of atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 66(15):1643–1653.
   PubMed Web of Science ®Google Scholar
• Morselli E, Santos RS, Criollo A, Nelson MD, Palmer BF, Clegg DJ. 2017. The effects of oestrogens and their receptors on cardiometabolic health. Nat Rev Endocrinol. 13(6):352–364.
   PubMed Web of Science ®Google Scholar
• Morselli E, Santos RS, Gao S, Ávalos Y, Criollo A, Palmer BF, Clegg DJ. 2018. Impact of estrogens and estrogen receptor-α in brain lipid metabolism. Am J Physiol Endocrinol Metab. 315(1):E7–E14.
   PubMed Web of Science ®Google Scholar
• Mu PW, Jiang P, Wang MM, Chen YM, Zheng SH, Tan Z, Jiang W, Zeng LY, Wang TH. 2016. Oestrogen exerts anti-inflammation via p38 MAPK/NF-κB cascade in adipocytes. Obes Res Clin Pract. 10(6):633–641.
   PubMed Web of Science ®Google Scholar
• Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, Uchino H. 2015. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol. 8(2):189–199.
   PubMed Web of Science ®Google Scholar
• Peiffer DS, Ma E, Wyatt D, Albain KS, Osipo C. 2020. DAXX-inducing phytoestrogens inhibit ER + tumor initiating cells and delay tumor development. NPJ Breast Cancer. 6:37.
   PubMed Web of Science ®Google Scholar
• Petri MH, Laguna-Fernandez A, Arnardottir H, Wheelock CE, Perretti M, Hansson GK, Bäck M. 2017. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E–/– mice. Br J Pharmacol. 174(22):4043–4054.
   PubMed Web of Science ®Google Scholar
• Pollard KJ, Daniel JM. 2019. Nuclear estrogen receptor activation by insulin-like growth factor-1 in neuro-2A neuroblastoma cells requires endogenous estrogen synthesis and is mediated by mutually repressive MAPK and PI3K cascades. Mol Cell Endocrinol. 490:68–79.
   PubMed Web of Science ®Google Scholar
• Reddy NM, Potteti HR, Vegiraju S, Chen HJ, Tamatam CM, Reddy SP. 2015. PI3K-AKT signaling via Nrf2 protects against hyperoxia-induced acute lung injury, but promotes inflammation post-injury independent of Nrf2 in mice. PLOS One. 10(6):e0129676.
   PubMed Web of Science ®Google Scholar
• Schierbeck L. 2015. Primary prevention of cardiovascular disease with hormone replacement therapy. Climacteric. 18(4):492–497.
   PubMed Web of Science ®Google Scholar
• Sharma D, Gondaliya P, Tiwari V, Kalia K. 2019. Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signalling. Biomed Pharmacother. 109:1610–1619.
   PubMed Web of Science ®Google Scholar
• Thangapandiyan S, Ramesh M, Hema T, Miltonprabu S, Uddin MS, Nandhini V, Bavithra Jothi G. 2019. Sulforaphane potentially ameliorates arsenic induced hepatotoxicity in albino wistar rats: implication of PI3K/Akt/Nrf2 signaling pathway. Cell Physiol Biochem. 52:1203–1222.
   PubMedGoogle Scholar
• Torres-Villarreal D, Camacho A, Castro H, Ortiz-Lopez R, de la Garza AL. 2019. Anti-obesity effects of kaempferol by inhibiting adipogenesis and increasing lipolysis in 3T3-L1 cells. J Physiol Biochem. 75(1):83–88.
   PubMed Web of Science ®Google Scholar
• Wang C, Niimi M, Watanabe T, Wang Y, Liang J, Fan J. 2018. Treatment of atherosclerosis by traditional Chinese medicine: questions and quandaries. Atherosclerosis. 277:136–144.
   PubMed Web of Science ®Google Scholar
• Wang X, Jia W, Zhao A, Wang X. 2006. Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res. 20(5):335–341.
   PubMed Web of Science ®Google Scholar
• Wu P, Meng X, Zheng H, Zeng Q, Chen T, Wang W, Zhang X, Su J. 2018. Kaempferol attenuates ROS-induced hemolysis and the molecular mechanism of its induction of apoptosis on bladder cancer. Molecules. 23:2592.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhao B, Zhang W, Jia L, Zhang Y, Xu X. 2020. Curcumin promotes osteogenic differentiation of periodontal ligament stem cells through the PI3K/AKT/Nrf2 signaling pathway. Iran J Basic Med Sci. 23(7):954–960.
   PubMed Web of Science ®Google Scholar
• Xu YP, Han F, Tan J. 2017. Edaravone protects the retina against ischemia/reperfusion-induced oxidative injury through the PI3K/Akt/Nrf2 pathway. Mol Med Rep. 16(6):9210–9216.
   PubMed Web of Science ®Google Scholar
• Yang K, Zhang H, Luo Y, Zhang J, Wang M, Liao P, Cao L, Guo P, Sun G, Sun X. 2017. Gypenoside XVII prevents atherosclerosis by attenuating endothelial apoptosis and oxidative stress: insight into the ERα-mediated PI3K/Akt pathway. Int J Mol Sci. 18:77.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang C, Jin Y, Ma X, Xie T, Wang J, Liu K, Sun H. 2019. Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR–/– mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis. Pharmacol Res. 148:104414.
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang Q, Zhou Q, Wang R, Xu M, Wang H, Wang L, Wilcox CS, Liu R, Lai EY. 2016. Protective effect of tempol on acute kidney injury through PI3K/Akt/Nrf2 signaling pathway. Kidney Blood Press Res. 41(2):129–138.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang Y, Zhang M, Gu L, Liu Z, Jia J, Chen X. 2016. Effects of phospholipid complexes of total flavonoids from persimmon (Diospyros kaki L.) leaves on experimental atherosclerosis rats. J Ethnopharmacol. 191:245–253.
   PubMed Web of Science ®Google Scholar
• Zhong X, Zhang L, Li Y, Li P, Li J, Cheng G. 2018. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of miR-26a-5p via inhibiting TLR4/NF-κB pathway in human endothelial cells. Biomed Pharmacother. 108:1783–1789.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Kang J, Xu G, Li J, Zhou H, Liu Y. 2020. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: study protocol for a randomized controlled multicenter trial. Medicine. 99(11):e19501.
   PubMed Web of Science ®Google Scholar